2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Classical hematology
1
Conditions
Marijuana Abuse
3
Neoplasms
2
Epilepsy
2
Tourette Syndrome
1
Stress Disorders, Post-Traumatic
1
Sleep Initiation and Maintenance Disorders
1
Severe Acute Respiratory Syndrome
1
Seizures
1
Parkinson Disease
1
Pancreatic Cancer Non-resectable
1
Pain
1
Opioid-Related Disorders
1
Neurodevelopmental Disorders
1
Multiple Sclerosis
1
Marijuana Use
1
Inflammatory Bowel Diseases
1
Hepatitis C
1
Glaucoma
1
Fibromyalgia
1
Depression
1
Crohn Disease
1
Coronavirus Infections
1
Colitis, Ulcerative
1
Chronic Traumatic Encephalopathy
1
Chronic Pain
1
Carcinoma, Hepatocellular
1
COVID-19
1
Brain Injuries, Traumatic
1
Bipolar Disorder
1
Autistic Disorder
1
Interventions
Cognitive Behavioral Therapy
30
Acupuncture Therapy
6
Surveys and Questionnaires
4
Behavior Therapy
4
Standard of Care
3
Electroacupuncture
3
Control Groups
3
Breathing Exercises
3
Aromatherapy
3
suvorexant
2
Zolpidem
2
Yoga
2
Saline Solution
2
Modafinil
2
Mindfulness-Based Stress Reduction
2
Exercise
2
zopiclone
1
ziprasidone
1
ramelteon
1
pegfilgrastim
1
enzalutamide
1
darolutamide
1
cyclobenzaprine
1
apalutamide
1
Water
1
Warfarin
1
Vecuronium Bromide
1
Vancomycin
1
Uncertainty
1
Tranexamic Acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Sleep Initiation and Maintenance Disorders
×
Medical Marijuana
×
Clear all
NCT03944447
2022-06-02
OMNI-Can
OMNI Medical Services, LLC
Phase 2
Unknown
200,000 enrolled